BioCentury
ARTICLE | Clinical News

Dyloject diclofenac sodium: Preliminary Phase II/III data

July 18, 2005 7:00 AM UTC

Innovative Drug Delivery Systems Inc., New York, N.Y. Product: Dyloject diclofenac sodium Business: Neurology Molecular target: Cyclooxygenases (COX) Description: Non-steroidal anti-inflammatory dru...